Blood-based biomarkers could enable simple, accurate TB tests for diagnosis and monitoring

Researchers have identified blood-based biomarkers in patients with active tuberculosis that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure. Tuberculosis (TB) is a major global public health problem. In 2013 alone, there were an estimated nine million cases of ATB disease, and 1.5 million people died from TB. In addition, the World Health Organization estimates that two billion individuals are asymptomatically infected with Mycobacterium tuberculosis (Mtb), the bacterium that causes TB, and are considered to have latent Mtb infection (LTBI).



from Today's Healthcare News -- ScienceDaily http://ift.tt/1COVpow